The enduring success of copyright’s flagship drug has undeniably shaped the pharmaceutical landscape. However, investing in companies heavily reliant on generic versions and the waning patent protection https://wearethelist.com/story23544839/sildenafil-and-pharmaceutical-companies-a-risky-venture